SAV1 Inhibitors

SAV1 Inhibitors comprise a variety of compounds that indirectly inhibit the activity of Salvador homolog 1 (SAV1), a crucial scaffold protein in the Hippo signaling pathway. This pathway regulates important cellular processes such as organ size, tissue homeostasis, cell proliferation, and apoptosis. The inhibitors in this group target various signaling pathways and cellular processes that intersect with or influence the Hippo pathway. These compounds include kinase inhibitors, molecules affecting signal transduction, and agents that modify cytoskeletal dynamics and cell adhesion. By influencing these pathways and processes, these inhibitors can indirectly reduce the activity or functionality of SAV1. For example, inhibitors that disrupt YAP-TEAD interactions or those affecting the Wnt or Hedgehog pathways can lead to changes in the Hippo pathway, subsequently modulating the activity of SAV1.

This inhibitor class exemplifies the complexity of targeting specific proteins within extensive signaling networks. The indirect nature of these inhibitors' action on SAV1 highlights the interconnectivity of cellular signaling pathways. For instance, compounds altering the Rho pathway or kinase activities associated with the Hippo pathway can lead to downstream effects that inhibit SAV1's role.